These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34949198)

  • 1. Combined integrin α
    Qi N; Zhang S; Zhou X; Duan W; Gao D; Feng J; Li A
    J Nanobiotechnology; 2021 Dec; 19(1):446. PubMed ID: 34949198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma.
    Kang S; Duan W; Zhang S; Chen D; Feng J; Qi N
    Theranostics; 2020; 10(10):4308-4322. PubMed ID: 32292496
    [No Abstract]   [Full Text] [Related]  

  • 3. "Guide" of muscone modification enhanced brain-targeting efficacy and anti-glioma effect of lactoferrin modified DTX liposomes.
    Qi N; Duan W; Gao D; Ma N; Zhang J; Feng J; Li A
    Bioeng Transl Med; 2023 Mar; 8(2):e10393. PubMed ID: 36925685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
    Yang ZZ; Li JQ; Wang ZZ; Dong DW; Qi XR
    Biomaterials; 2014 Jun; 35(19):5226-39. PubMed ID: 24695093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.
    Wang H; Zhu Z; Zhang G; Lin F; Liu Y; Zhang Y; Feng J; Chen W; Meng Q; Chen L
    J Pharm Sci; 2019 Nov; 108(11):3684-3694. PubMed ID: 31465736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
    Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
    Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes actively recognizing the glucose transporter GLUT
    Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y
    Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy.
    Liu Y; Mei L; Xu C; Yu Q; Shi K; Zhang L; Wang Y; Zhang Q; Gao H; Zhang Z; He Q
    Theranostics; 2016; 6(2):177-91. PubMed ID: 26877777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes Combined an Integrin αvβ3-Specific Vector with pH-Responsible Cell-Penetrating Property for Highly Effective Antiglioma Therapy through the Blood-Brain Barrier.
    Shi K; Long Y; Xu C; Wang Y; Qiu Y; Yu Q; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2015 Sep; 7(38):21442-54. PubMed ID: 26371468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
    Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
    Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
    Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
    Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906).
    Scherzinger-Laude K; Schönherr C; Lewrick F; Süss R; Francese G; Rössler J
    Int J Nanomedicine; 2013; 8():2197-211. PubMed ID: 23818777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple branched RGD modification on liposomes: A prospective strategy to enhance the glioma targeting efficiency.
    Li Z; Lu J; Tang B; Shi Y; Hai L; Guo L; Wu Y
    Bioorg Med Chem; 2022 Apr; 60():116704. PubMed ID: 35286953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor effect on intrapulmonary tumors of docetaxel lung-targeted liposomes in a rabbit model of VX2 orthotopic lung cancer.
    Wang L; Li R; Che K; Liu Z; Xiang S; Li M; Yu Y
    Sci Rep; 2017 Aug; 7(1):10069. PubMed ID: 28855665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model.
    Qi N; Zhou X; Ma N; Zhang J; Wang Z; Zhang X; Li A
    Int J Nanomedicine; 2024; 19():3071-3086. PubMed ID: 38562611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
    Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
    Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering.
    Guo Z; He B; Jin H; Zhang H; Dai W; Zhang L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Biomaterials; 2014 Jul; 35(23):6106-17. PubMed ID: 24794924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells.
    Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
    Biomaterials; 2013 Jul; 34(22):5617-27. PubMed ID: 23623323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging.
    Chauhan M; Sonali ; Shekhar S; Yadav B; Garg V; Dutt R; Mehata AK; Goswami P; Koch B; Muthu MS; Singh RP
    Biomater Adv; 2024 Jun; 160():213833. PubMed ID: 38564997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
    Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
    Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.